The beat-and-raise quarter with accelerating subscription growth and strong AI product momentum (Falcon, Vault AI) supports a bullish thesis. Traders should watch for continued top-20 biopharma wins and Falcon go-lives in H2 as catalysts. The raised guidance provides a clear upward earnings trajectory, making VEEV attractive for long positions ahead of the Q3 report.
Price Chart
Executive Summary
Veeva Systems reported fiscal Q2 2027 results that exceeded guidance on all metrics, with total revenue of $928.0M (+18% YoY) and non-GAAP EPS of $2.35, beating the $2.22 consensus by 5.9%. The company raised its full-year revenue guidance to $3.682-$3.687B and non-GAAP EPS to ~$9.21, signaling accelerating momentum in its core life sciences cloud business, particularly Vault CRM and the new Falcon AI platform. The strong beat and raised guidance are a clear bullish signal for the stock, supported by robust subscription revenue growth and operating leverage.
Key Financial Metrics
Key Facts
- Total revenues of $928.0M, up 18% YoY, above consensus of $905.3M.
- Non-GAAP diluted EPS of $2.35, beating consensus of $2.22 by 5.9%.
- Subscription revenues of $766.8M, up 16% YoY, driven by Vault CRM and R&D/Quality Solutions.
- Operating income of $275.0M (GAAP) and $415.9M (non-GAAP), up 40% and 18% YoY respectively.
- Raised full-year FY2027 guidance: revenue to $3.682-$3.687B and non-GAAP EPS to ~$9.21.
- Vault CRM secured 5 top-20 biopharma wins in the quarter, with 12 total top-20 commitments globally.
- Veeva Falcon AI platform launched with 5 early adopters, on track for initial go-lives this year.
- Operating cash flow of $238.7M for the quarter, up from $238.4M YoY.
- Repurchased $472.7M of common stock in H1 FY2027.
Financial Impact
Revenue beat of $22.7M (+2.5% vs consensus) and EPS beat of $0.13 (+5.9% vs consensus). Full-year guidance raised by ~$30M at midpoint.
Risk Factors
- Guidance assumes continued execution; any slowdown in top-20 biopharma adoption could disappoint.
- AI product ramp (Falcon) is early-stage; go-live delays or adoption misses could weigh on sentiment.
- Stock-based compensation remains elevated at $136.8M for the quarter, diluting GAAP earnings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302860933 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 26, 2026 5w ago | Press Release | $282.13 $278.39 | ▼ −1.33% | ▼ −1.22% | $274.52 (−2.70%) |
Jun 3, 2026 17w ago | 8-K | $178.54 $192.74 | ▲ +7.96% | ▲ +9.58% | $274.52 (+53.76%) |
May 4, 2026 21w ago | DEFA14A | $170.18 $188.66 | ▲ +10.86% | ▲ +5.22% | $274.52 (+61.31%) |
Apr 20, 2026 23w ago | 8-K | $167.71 $163.85 | ▼ −2.30% | ▼ −7.21% | $274.52 (+63.69%) |
Mar 4, 2026 30w ago | 8-K | $195.27 $173.86 | ▼ −10.96% | ▼ −7.18% | $274.52 (+40.59%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access